This page shows the latest Relief Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Relief Therapeutics has announced that its NeuroRX-partnered COVID-19 drug RLF-100 met the survival threshold in intensive care patients and added that it expects detailed trial data this year. ... Relief and NeuroRx are still awaiting the detailed
According to Relief Therapeutics, patients treated with RLF-100 demonstrated a three-fold advantage in survival, as well as recovery from respiratory failure and other clinical improvement parameters. ... The pursuit of EUA status is a crucial component
Drug produced rapid recovery in critically-ill patients. NeuroRx and Relief Therapeutics have announced that their investigational therapeutic RLF-100 produces rapid recovery from respiratory failure in critically-ill COVID-19 ... NeuroRx and Relief have
FDA says PEGPH20 trial can continue. There was relief for Halozyme Therapeutics after it was told it can resume a clinical study investigating a potential treatment for pancreatic cancer.
More from news
Approximately 3 fully matching, plus 1 partially matching documents found.
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...